Tissue Regeneration Systems, Inc.
Country not established
- Devices
- 1
What Tissue Regeneration Systems, Inc. makes
Tissue Regeneration Systems, Inc. manufactures the TRS Cranial Bone Void Filler (TRS C-BVF), a device designed to fill cranial bone defects and support bone regeneration in surgical applications.
The company’s portfolio is regulated under FDA’s Class II device classification, with the TRS C-BVF authorised via the 510(k) pathway. The device is listed in the FDA’s 510(k) registry. The manufacturer is based in the United States.
Catalogue
Trs Cranial Bone Void Filler(Trs C-Bvf) Ref K123633
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Tissue Regeneration Systems, Inc. have in the registry?
The registry currently lists 1 device for Tissue Regeneration Systems, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Tissue Regeneration Systems, Inc.'s devices?
Among its 1 most recently registered device, Tissue Regeneration Systems, Inc. has devices listed in FDA 510(k) (1 device).
What risk classes do Tissue Regeneration Systems, Inc.'s devices fall under?
Among its 1 most recently registered device, the classes recorded for Tissue Regeneration Systems, Inc.'s devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Tissue Regeneration Systems, Inc. in the registry?
The most recently registered devices listed for Tissue Regeneration Systems, Inc. include TRS CRANIAL BONE VOID FILLER(TRS C-BVF).